|
 |
| home > epc > summer 2004 > eu expansion - breaking down the language, culture, and consumer communications barriers |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
On 1st May 2004, 10 countries joined the European Union, bringing the total community to 25 nations. This momentous event, involving a population increase of 19 per cent, means additional market opportunities for pharmaceutical firms. However, reaching these new customers means communicating in more languages, through different channels, and tailoring your message and approach to the unique cultures and heritages of these countries and regions.
Compounding this challenge is the fact that the expansion is occurring at a time when the EU is seeking to foster a more open and competitive drug market, fuelling demand for increased advertising and direct-to-consumer (DTC) marketing. To offset the potential risks of this dynamic environment, the EU is simultaneously seeking to strengthen its control and influence over the content and communication practices employed by pharmaceutical manufacturers to reach and serve their customers.
So what effect will this expansion have on communications and marketing campaigns? What linguistic and cultural perspectives must be considered when creating and delivering the right message? What, if anything, can be done to make this effort less taxing and speed share gains in these markets?
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
“PACK DIFFERENT” with EMBALLAGE 2008
“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >> |
|
 |
